INmune Bio
INMB
$6.84
Share price
-6.30%
Change (1 day)
-33.98%
Change (1 year)
Categories
Revenue for INmune Bio (INMB)
Revenue in 2024 (TTM): $0.01 Million USD
According to INmune Bio's latest financial reports the company's current revenue (TTM 
) is $0.01 Million USD. a decrease over the revenue in the year 2023 that were of $0.15 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for INmune Bio from 2018 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | $0.01 M | -90.97% |
| 2023 | $0.15 M | -58.56% |
| 2022 | $0.37 M | 106.63% |
| 2021 | $0.18 M | 1558.12% |
| 2020 | $0.01 M | |
| 2019 | N/A | |
| 2018 | N/A |